These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. Gao XM; Wong G; Wang B; Kiriazis H; Moore XL; Su YD; Dart A; Du XJ J Hypertens; 2006 Aug; 24(8):1663-70. PubMed ID: 16877971 [TBL] [Abstract][Full Text] [Related]
28. Alterations in cardiac gene expression during ventricular remodeling following experimental myocardial infarction. Gidh-Jain M; Huang B; Jain P; Gick G; El-Sherif N J Mol Cell Cardiol; 1998 Mar; 30(3):627-37. PubMed ID: 9515038 [TBL] [Abstract][Full Text] [Related]
29. Akt1 is required for physiological cardiac growth. DeBosch B; Treskov I; Lupu TS; Weinheimer C; Kovacs A; Courtois M; Muslin AJ Circulation; 2006 May; 113(17):2097-104. PubMed ID: 16636172 [TBL] [Abstract][Full Text] [Related]
30. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice. Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112 [TBL] [Abstract][Full Text] [Related]
31. Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy. Shi J; Zhang YW; Summers LJ; Dorn GW; Wei L J Mol Cell Cardiol; 2008 Mar; 44(3):551-60. PubMed ID: 18178218 [TBL] [Abstract][Full Text] [Related]
32. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction. van Rooij E; Doevendans PA; Crijns HJ; Heeneman S; Lips DJ; van Bilsen M; Williams RS; Olson EN; Bassel-Duby R; Rothermel BA; De Windt LJ Circ Res; 2004 Feb; 94(3):e18-26. PubMed ID: 14739160 [TBL] [Abstract][Full Text] [Related]
33. Cardiac-specific PID1 overexpression enhances pressure overload-induced cardiac hypertrophy in mice. Liu Y; Shen Y; Zhu J; Liu M; Li X; Chen Y; Kong X; Song G; Qian L Cell Physiol Biochem; 2015; 35(5):1975-85. PubMed ID: 25871431 [TBL] [Abstract][Full Text] [Related]
34. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways. Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128 [TBL] [Abstract][Full Text] [Related]
35. [Is secondary myocardial hypertrophy a physiological or pathological adaptive mechanism?]. Krayenbühl HP Z Kardiol; 1982 Aug; 71(8):489-96. PubMed ID: 6215776 [TBL] [Abstract][Full Text] [Related]
36. Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility. Pasipoularides A J Cardiovasc Transl Res; 2016 Aug; 9(4):374-99. PubMed ID: 27184804 [TBL] [Abstract][Full Text] [Related]
37. Genetic ablation of TRPV1 exacerbates pressure overload-induced cardiac hypertrophy. Zhong B; Rubinstein J; Ma S; Wang DH Biomed Pharmacother; 2018 Mar; 99():261-270. PubMed ID: 29334670 [TBL] [Abstract][Full Text] [Related]
38. Heme Induces IL-6 and Cardiac Hypertrophy Genes Transcripts in Sickle Cell Mice. Gbotosho OT; Kapetanaki MG; Ghosh S; Villanueva FS; Ofori-Acquah SF; Kato GJ Front Immunol; 2020; 11():1910. PubMed ID: 32973791 [TBL] [Abstract][Full Text] [Related]
39. Induction and analysis of cardiac hypertrophy in transgenic animal models. Barbosa ME; Alenina N; Bader M Methods Mol Med; 2005; 112():339-52. PubMed ID: 16010028 [TBL] [Abstract][Full Text] [Related]